RxDoctor Payments DataLook up a doctor →

Paul Farabaugh, MD

Urology · Tupelo, MSNPI 1881694347

Payments from drug & device makers

$12,533in general payments, 2019–2025

Across 363 payments — averaging $34.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dendreon Pharmaceuticals LLC$3K
  • Astellas Pharma US Inc$1K
  • Medtronic$944
  • Boston Scientific$884
  • Axonics, Inc.$800
  • Teleflex LLC$714
  • plus $5K from 36 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Dendreon Pharmaceuticals LLC35$2,889
Astellas Pharma US Inc68$1,065
Medtronic(2 entities)16$944
Boston Scientific16$884
Axonics, Inc.29$800
Teleflex LLC9$714
Johnson & Johnson(2 entities)19$462
Myriad Genetic Laboratories, Inc.9$425
Bayer17$394
Urogen Pharma, Inc.14$364
Procept Biorobotics Corporation3$351
Pfizer19$315
Neotract Inc.3$309
Merck16$300
Sumitomo Pharma America, Inc.16$296
Laborie Medical Technologies Corp.3$265
Intuitive Surgical2$200
Cook Medical LLC2$163
180 Medical, Inc.7$149
Olympus Corporation Of The Americas1$111
AbbVie(2 entities)7$109
Amgen7$106
Myovant Sciences Inc.6$103
Endo USA, Inc.2$83
Tolmar Pharmaceuticals, Inc.4$71
Coloplast3$71
Novartis3$70
Olympus America Inc.4$69
Blue Earth Diagnostics3$64
Ferring Pharmaceuticals Inc.3$54
SRS Medical Systems, Inc.1$48
Cumberland Pharmaceuticals, Inc.3$48
Endo Pharmaceuticals Inc.3$44
Verity Pharmaceuticals Inc.2$30
Alnylam Pharmaceuticals Inc.1$29
Immunitybio, Inc.1$25
Rochester Medical Corporation1$23
Convatec Inc.1$20
Travere Therapeutics, Inc.1$18
Innovation Technologies Inc1$18
Halozyme Inc1$16
AstraZeneca1$14

How this compares

$12,533 in reported general payments places this provider in the 90th percentile of 94 urology providers in Mississippi.

See all urology providers in Mississippi →

Medicare billing

Part B allowed, 2024
$824,554
Medicare patients
595
Services billed
11,710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Tupelo

See the full list for Mississippi →

Where these figures come from

Is this you, or does something look wrong? →